You just read:

JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer

News provided by

JHL Biotech

10 Aug, 2018, 06:54 IST